{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:23:09Z","timestamp":1773087789798,"version":"3.50.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Functional IgG autoantibodies against diverse G protein-coupled receptors, i.e. antibodies with agonistic or antagonistic activity at these receptors, are abundant in human serum. Their levels are altered in patients with SSc, and autoantibodies against angiotensin II receptor 1 (ATR1) and endothelin receptor A (ETA) have been suggested to drive SSc by inducing the chemokines CXCL8 and CCL18 in the blood. The objective of our study is to profile the effect of IgG in SSc (SSc-IgG) on the production of soluble mediators in monocytic cells.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Monocyte-like THP-1 cells were stimulated with SSc-IgG and their secretome was analysed. Furthermore, the significance of major pro-inflammatory pathways for the induction of CXCL8 and CCL18 in response to SSc-IgG was assessed by a pharmacological approach.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Stimulation with SSc-IgG significantly alters the secretome of THP-1 cells towards a general pro-inflammatory and profibrotic phenotype, which includes an increase of CCL18 and CXCL8. The consequent expression profiles vary depending on the individual donor of the SSc-IgG. CCL18 and CXCL8 expression is thus regulated differentially, with AP-1 driving the induction of both CCL18 and CXCL8 and the TAK\/IKK-\u03b2\/NF-\u03baB pathway and ERK1\/2 driving that of CXCL8.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our results suggest that SSc-IgG contributes to the generation of the pro-inflammatory\/profibrotic tissue milieu characteristic of SSc by its induction of a respective phenotype in monocytes. Furthermore, our results highlight AP-1 as a critical regulator of gene transcription of CCL18 in monocytic cells and as a promising pharmacological therapeutic target for the treatment of SSc.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa747","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T11:12:25Z","timestamp":1603537945000},"page":"3012-3022","source":"Crossref","is-referenced-by-count":11,"title":["Immunoglobulin G of systemic sclerosis patients programs a pro-inflammatory and profibrotic phenotype in monocyte-like THP-1 cells"],"prefix":"10.1093","volume":"60","author":[{"given":"Sripriya","family":"Murthy","sequence":"first","affiliation":[{"name":"Department of Dermatology, Allergy, and Venereology, University of L\u00fcbeck, L\u00fcbeck, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Wannick","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Allergy, and Venereology, University of L\u00fcbeck, L\u00fcbeck, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Eleftheriadis","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Allergy, and Venereology, University of L\u00fcbeck, L\u00fcbeck, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antje","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Clinic for Rheumatology and Clinical Immunology, University of L\u00fcbeck, L\u00fcbeck, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Luo","sequence":"additional","affiliation":[{"name":"Clinic for Rheumatology and Clinical Immunology, University of L\u00fcbeck, L\u00fcbeck, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hauke","family":"Busch","sequence":"additional","affiliation":[{"name":"Center for Research on Inflammation of the Skin (CRIS), University of L\u00fcbeck, L\u00fcbeck, Germany"},{"name":"L\u00fcbeck Institute for Experimental Dermatology, University of L\u00fcbeck, L\u00fcbeck, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Dalmann","sequence":"additional","affiliation":[{"name":"Clinic for Rheumatology and Clinical Immunology, University of L\u00fcbeck, L\u00fcbeck, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Riemekasten","sequence":"additional","affiliation":[{"name":"Clinic for Rheumatology and Clinical Immunology, University of L\u00fcbeck, L\u00fcbeck, Germany"},{"name":"Center for Research on Inflammation of the Skin (CRIS), University of L\u00fcbeck, L\u00fcbeck, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6701-048X","authenticated-orcid":false,"given":"Christian D","family":"Sadik","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Allergy, and Venereology, University of L\u00fcbeck, L\u00fcbeck, Germany"},{"name":"Center for Research on Inflammation of the Skin (CRIS), University of L\u00fcbeck, L\u00fcbeck, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"key":"2021061821285506300_keaa747-B1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2008.08.040","article-title":"Anatomical profiling of G protein-coupled receptor expression","volume":"135","author":"Regard","year":"2008","journal-title":"Cell"},{"key":"2021061821285506300_keaa747-B2","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.autrev.2016.03.005","article-title":"Vascular hypothesis revisited: role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis","volume":"15","author":"Cabral-Marques","year":"2016","journal-title":"Autoimmun Rev"},{"key":"2021061821285506300_keaa747-B3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13075-018-1545-8","article-title":"Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis","volume":"20","author":"Weigold","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2021061821285506300_keaa747-B4","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nrrheum.2017.134","article-title":"Functional autoantibodies targeting G protein-coupled receptors in rheumatic diseases","volume":"13","author":"Cabral-Marques","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"2021061821285506300_keaa747-B5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/jpet.114.221606","article-title":"Endogenous allosteric modulators of G protein-coupled receptors","volume":"353","author":"van der Westhuizen","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"2021061821285506300_keaa747-B6","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/ijcp.12242","article-title":"The role of angiotensin II type 1 receptor-activating antibodies in patients with lupus nephritis","volume":"67","author":"Xiong","year":"2013","journal-title":"Int J Clin Pract"},{"key":"2021061821285506300_keaa747-B7","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1002\/art.39212","article-title":"Anti-endothelin receptor type A autoantibodies in systemic lupus erythematosus-associated pulmonary arterial hypertension","volume":"67","author":"Guo","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2021061821285506300_keaa747-B8","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2010.135772","article-title":"Involvement of functional autoantibodies against vascular receptors in systemic sclerosis","volume":"70","author":"Riemekasten","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2021061821285506300_keaa747-B9","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar4503","article-title":"Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients","volume":"16","author":"Gunther","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2021061821285506300_keaa747-B10","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar4457","article-title":"Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis","volume":"16","author":"Kill","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2021061821285506300_keaa747-B11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1024\/0301-1526\/a000372","article-title":"G-protein coupled receptor auto-antibodies in thromboangiitis obliterans (Buerger\u2019s disease) and their removal by immunoadsorption","volume":"43","author":"Klein-Weigel","year":"2014","journal-title":"Vasa"},{"key":"2021061821285506300_keaa747-B12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcf.2014.07.007","article-title":"Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis","volume":"14","author":"Budding","year":"2015","journal-title":"J Cyst Fibros"},{"key":"2021061821285506300_keaa747-B13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J Clin Invest"},{"key":"2021061821285506300_keaa747-B14","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"2021061821285506300_keaa747-B15","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1164\/rccm.201403-0442OC","article-title":"Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis","volume":"190","author":"Becker","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2021061821285506300_keaa747-B16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11926-015-0505-4","article-title":"Functional autoantibodies in systemic sclerosis pathogenesis","volume":"17","author":"Kill","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"2021061821285506300_keaa747-B17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.chest.2016.03.004","article-title":"High level of chemokine CCL18 is associated with pulmonary function deterioration, lung fibrosis progression, and reduced survival in systemic sclerosis","volume":"150","author":"Hoffmann-Vold","year":"2016","journal-title":"Chest"},{"key":"2021061821285506300_keaa747-B18","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1186\/ar2766","article-title":"Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients","volume":"11","author":"Schmidt","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"2021061821285506300_keaa747-B19","first-page":"S46","article-title":"Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis","volume":"29","author":"Riccieri","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"2021061821285506300_keaa747-B20","first-page":"1524","article-title":"Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-\u03b1 are elevated in patients with systemic sclerosis","volume":"30","author":"Furuse","year":"2003","journal-title":"J Rheumatol"},{"key":"2021061821285506300_keaa747-B21","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/ard.2010.137349","article-title":"An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis","volume":"70","author":"Codullo","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2021061821285506300_keaa747-B22","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/art.41020","article-title":"Progression of interstitial lung disease in systemic sclerosis: the importance of pneumoproteins Krebs von den Lungen 6 and CCL18","volume":"71","author":"Volkmann","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2021061821285506300_keaa747-B23","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/art.40815","article-title":"Performance of candidate serum biomarkers for systemic sclerosis-associated interstitial lung disease","volume":"71","author":"Elhai","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2021061821285506300_keaa747-B24","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1002\/art.21257","article-title":"Serum pulmonary and activation-regulated chemokine\/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis","volume":"52","author":"Kodera","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2021061821285506300_keaa747-B25","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1084\/jem.20130240","article-title":"Identification of human CCR8 as a CCL18 receptor","volume":"210","author":"Islam","year":"2013","journal-title":"J Exp Med"},{"key":"2021061821285506300_keaa747-B26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1189\/jlb.1204712","article-title":"Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes","volume":"78","author":"Schutyser","year":"2005","journal-title":"J Leukoc Biol"},{"key":"2021061821285506300_keaa747-B27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bcp.2016.04.005","article-title":"The impact of RGS and other G-protein regulatory proteins on G\u03b1i-mediated signaling in immunity","volume":"114","author":"Kehrl","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"2021061821285506300_keaa747-B28","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.cellsig.2014.02.010","article-title":"Implications of non-canonical G-protein signaling for the immune system","volume":"26","author":"Boularan","year":"2014","journal-title":"Cell Signal"},{"key":"2021061821285506300_keaa747-B29","doi-asserted-by":"crossref","first-page":"15268","DOI":"10.1074\/jbc.M109.076232","article-title":"Pertussis toxin up-regulates angiotensin type 1 receptors through Toll-like receptor 4-mediated Rac activation","volume":"285","author":"Nishida","year":"2010","journal-title":"J Biol Chem"},{"key":"2021061821285506300_keaa747-B30","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S1357-2725(02)00300-X","article-title":"Angiotensin II signaling pathways mediated by tyrosine kinases","volume":"35","author":"Yin","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"2021061821285506300_keaa747-B31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1476-5381.2012.02190.x","article-title":"Pro-fibrotic processes in human lung fibroblasts are driven by an autocrine\/paracrine endothelinergic system","volume":"168","author":"Ahmedat","year":"2013","journal-title":"Br J Pharmacol"},{"key":"2021061821285506300_keaa747-B32","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/MCB.01225-13","article-title":"S6K1 negatively regulates TAK1 activity in the toll-like receptor signaling pathway","volume":"34","author":"Kim","year":"2014","journal-title":"Mol Cell Biol"},{"key":"2021061821285506300_keaa747-B33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.it.2013.03.007","article-title":"Cell type-specific function of TAK1 in innate immune signaling","volume":"34","author":"Ajibade","year":"2013","journal-title":"Trends Immunol"},{"key":"2021061821285506300_keaa747-B34","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/annrheumdis-2012-201958","article-title":"Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors","volume":"72","author":"Ciechomska","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2021061821285506300_keaa747-B35","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/labinvest.2010.73","article-title":"Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype","volume":"90","author":"Mathai","year":"2010","journal-title":"Lab Invest"},{"key":"2021061821285506300_keaa747-B36","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/ar3066","article-title":"Characterization of monocyte\/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis","volume":"12","author":"Higashi-Kuwata","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"2021061821285506300_keaa747-B37","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/art.22382","article-title":"A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and Toll-like receptor agonists","volume":"56","author":"York","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021061821285506300_keaa747-B38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-1536-4-15","article-title":"Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide","volume":"4","author":"Tourkina","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"key":"2021061821285506300_keaa747-B39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fcell.2016.00021","article-title":"Induction of macrophage function in human THP-1 cells is associated with rewiring of MAPK signaling and activation of MAP3K7 (TAK1) protein kinase","volume":"4","author":"Richter","year":"2016","journal-title":"Front Cell Dev Biol"},{"key":"2021061821285506300_keaa747-B40","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/art.39602","article-title":"Histone demethylation and Toll-like receptor 8-dependent cross-talk in monocytes promotes transdifferentiation of fibroblasts in systemic sclerosis via Fra-2","volume":"68","author":"Ciechomska","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2021061821285506300_keaa747-B41","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.autrev.2017.12.010","article-title":"Efficacy and safety of rituximab in systemic sclerosis: French retrospective study and literature review","volume":"17","author":"Thiebaut","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2021061821285506300_keaa747-B42","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/art.40560","article-title":"Treatment algorithms for systemic sclerosis according to experts","volume":"70","author":"Fernandez-Codina","year":"2018","journal-title":"Arthritis Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/6\/3012\/38694952\/keaa747.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/6\/3012\/38694952\/keaa747.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T21:29:57Z","timestamp":1624051797000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/6\/3012\/5999090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,11,23]]},"published-print":{"date-parts":[[2021,6,18]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa747","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2020,11,23]]}}}